First Disposable Cath Lab Robot Technology Acquired by Ascendum Start-up EndoWays technology supports navigation and operation within blood vessels in neurovascular, peripheral and cardiac procedures The EndoWays disposable robotic system for cath lab procedural navigation. February 9, 2021 — EndoWays, developer of a disposable robotic system for the cath lab, announced the completion of an acquisition of a majority of its shares by Ascendum for an undisclosed cash amount. EndoWays, which was founded in 2018 by Noam Shamay, Tovy Sivan and Tamir Ben David, is a portfolio company of Medx Xelerator. During its incubation time, EndoWays developed a first-of-its-kind, fully disposable robotic system to support navigation and operation within blood vessels in neurovascular, peripheral and cardiac procedures. The deal will provide EndoWays with access to the vast experience and network of the Ascendum team, helping accelerate its clinical and commercial development, especially in China.